Ostenil injection for osteoarthritis with hyaluronic acid, rheumatology

OSTENIL®
Pre-filled syringe 2 ml

OSTENIL® is indicated to relieve pain and improve mobility in degenerative and traumatic changes of synovial joints degenerative changes, such as osteoarthritis.

The aim of the injection is to increase the concentration of hyaluronic acid in the joint, which often decreases as a result of osteoarthritis. The structure of the hyaluronic acid contained in OSTENIL®, OSTENIL® PLUS and OSTENIL® MINI matches human hyaluronic acid.

OSTENIL®: pre-filled syringe to relieve pain induced by osteoarthritis. Effective, safe and well-tolerated.

  • 1% hyaluronic acid obtained by biofermentation
  • 3-5 injections at weekly intervals
  • For all synovial joints

Specification

 

Packaging

Volume

Main ingredient
Pre-filled syringe 2 ml 1% Hyaluronic acid

Dosage and administration method

Inject OSTENIL® into the affected joint once a week for a total of 3–5 injections. Several joints may be treated at the same time. Depending on the severity of the joint disease the beneficial effects of a treatment cycle of five intra-articular injections will last at least six months. Repeat treatment cycles may be administered as required. In case of joint effusion it is advisable to reduce the effusion by aspiration, rest, application of an ice pack and/or intra-articular corticosteroid injection. Treatment with OSTENIL® can be started two to three days later. The content and the outer surface of the OSTENIL® pre-filled syringe are sterile as long as the sterile pack is intact. Take the pre-filled syringe out of the sterile pack, unscrew the Luer lock cap from the syringe, attach a suitable needle (for example 19 to 21 G) and secure it by turning slightly. Remove any air bubble, if present, before injection.

For medical use only

Ostenil joint pain acid hayluronic-TRB-Chemedica-EN-570×370

Proven to be effective

  • Relieves pain1-4
  • Improves mobility2, 4
  • Reduces use of painkillers4
  • High level of satisfaction among patients: more than 90% of patients rate the success of treatment as “very good”5-7
  • Treatment with hyaluronic acid is suitable for any synovial joint – from head to toe
Ostenil-rheumathology-arthrosis-hyaluronic-acid-block-2-TRB-Chemedica-EN-570×370

Safe and well-tolerated

  • Hyaluronic acid obtained by biofermentation
  • Final autoclave sterilisation (SAL6)
  • Optimal molecular weight
  • Structure matches that of the natural hyaluronic acid contained in the human body
TRB-Chemedica-Factory-Vouvry-Valais-Switzerland-ostenil-swiss-made-EN

MADE IN SWITZERLAND

With 20 years of experience, our production standards are among the highest with regular quality checks to guarantee a top-quality product. Made in Vouvry, Valais.

DOWNLOAD

  • OSTENIL® Brochure

    We cannot guarantee that the information displayed is tailored to a user’s individual situation. This brochure is therefore only provided for informational purposes. If you have a medical problem, we recommend that you contact your regular health care provider.

    Download
  • OSTENIL® Instructions for use

    We cannot guarantee that the information displayed is tailored to a user’s individual situation. This brochure is therefore only provided for informational purposes. If you have a medical problem, we recommend that you contact your regular health care provider.

    Download

Disclaimer: Local registration varies between countries. Not all products and /or pack sizes are registered. For full product information and actual packs please refer to your country registered product and prescribing information.


SIMILAR PRODUCTS

OSTENIL® PLUS

OSTENIL® MINI

OSTENIL® TENDON

References